MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-17-2026
Boston Scientific Corporation EV/EBITDA Ratio 2011-2026 | BSX
Annual EV/EBITDA Ratio Boston Scientific Corporation
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 25.2 | 39.1 | 28.8 | 25.9 | 20.9 | 20.2 | 19.4 | 17.4 | 17.2 | 10.8 | 6.09 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 39.1 | 6.09 | 21 |
EV/EBITDA Ratio of other stocks in the Medical devices industry
| Issuer | EV/EBITDA Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Aziyo Biologics
AZYO
|
-4.45 | - | 1.37 % | $ 20.5 M |  USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
-244 | - | - | $ 1.77 B | USA |
 |
Conformis
CFMS
|
-44.1 | - | - | $ 16.4 M | USA |
 |
Bruker Corporation
BRKR
|
-2.13 | $ 38.88 | -0.99 % | $ 5.79 K | USA |
 |
Lianluo Smart Limited
LLIT
|
-50.1 | - | 24.59 % | $ 44.8 M |  China |
 |
Cardiovascular Systems
CSII
|
-93.5 | - | 0.15 % | $ 844 M | USA |
 |
Cutera
CUTR
|
236 | - | -10.19 % | $ 1.99 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
-4.23 | - | -5.86 % | $ 30.6 M | USA |
 |
Acutus Medical
AFIB
|
-0.915 | - | -26.83 % | $ 2.62 M | USA |
 |
Dynatronics Corporation
DYNT
|
-2.59 | - | 14.99 % | $ 929 K | USA |
 |
Eargo
EAR
|
-1.15 | - | - | $ 10.2 M | USA |
 |
Cognyte Software Ltd.
CGNT
|
23 | $ 8.07 | 3.13 % | $ 579 M |  Israel |
 |
Allied Healthcare Products
AHPI
|
367 | - | 3.58 % | $ 2.21 M | USA |
 |
Second Sight Medical Products
EYES
|
3.87 | - | -0.97 % | $ 54.4 M | USA |
 |
AdaptHealth Corp.
AHCO
|
11 | $ 9.72 | 3.35 % | $ 1.31 B | USA |
 |
Apollo Endosurgery
APEN
|
-7.33 | - | - | $ 475 M | USA |
 |
EDAP TMS S.A.
EDAP
|
730 | $ 4.24 | 6.27 % | $ 158 M |  France |
 |
Electromed
ELMD
|
26.4 | $ 24.5 | 2.17 % | $ 207 M | USA |
 |
CONMED Corporation
CNMD
|
40.2 | $ 43.16 | -0.36 % | $ 1.34 B | USA |
 |
CryoLife, Inc.
CRY
|
49.1 | - | -4.14 % | $ 702 M | USA |
 |
FONAR Corporation
FONR
|
-33.4 | $ 18.54 | 0.19 % | $ 122 M | USA |
 |
Avinger
AVGR
|
-2.46 | - | -20.74 % | $ 369 K | USA |
 |
CHF Solutions, Inc.
CHFS
|
0.013 | - | 1.15 % | $ 34.5 M | USA |
 |
AxoGen
AXGN
|
-19.1 | $ 29.51 | -1.07 % | $ 1.36 B | USA |
 |
Apyx Medical Corporation
APYX
|
-29.2 | $ 3.26 | 2.84 % | $ 113 M | USA |
 |
Axonics Modulation Technologies
AXNX
|
-36 | - | - | $ 3.31 B | USA |
 |
Soliton, Inc.
SOLY
|
-14 | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
90.3 | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
-38.6 | - | 0.03 % | $ 1.58 B | Israel |
 |
Accuray Incorporated
ARAY
|
19.9 | $ 0.52 | -0.49 % | $ 53.4 M | USA |
 |
Misonix, Inc.
MSON
|
-12 | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
-20.2 | - | - | $ 111 M |  Canada |
 |
Medigus Ltd.
MDGS
|
-9.08 | - | 10.28 % | $ 55.5 M | Israel |
 |
Cytosorbents Corporation
CTSO
|
-4.76 | $ 0.79 | -1.75 % | $ 43 M | USA |
 |
Align Technology
ALGN
|
48.9 | $ 181.84 | -0.44 % | $ 13.6 B | USA |
 |
Intersect ENT, Inc.
XENT
|
-12.1 | - | - | $ 955 M | USA |
 |
Inari Medical
NARI
|
261 | - | - | $ 4.23 B | USA |
 |
Butterfly Network
BFLY
|
-3.9 | $ 4.0 | 8.11 % | $ 847 M | USA |
 |
BIOLASE
BIOL
|
-86.3 | - | -13.19 % | $ 166 K | USA |
 |
Abbott Laboratories
ABT
|
20.3 | $ 113.6 | 0.02 % | $ 198 B | USA |
 |
NuVasive
NUVA
|
16.3 | - | - | $ 2.07 B | USA |
 |
Nevro Corp.
NVRO
|
-23.6 | - | - | $ 217 M | USA |
 |
InMode Ltd.
INMD
|
23.3 | $ 13.57 | -0.26 % | $ 877 M | Israel |
 |
BioSig Technologies
BSGM
|
-1.88 | - | 37.08 % | $ 85.7 M | USA |
 |
IRadimed Corporation
IRMD
|
46 | $ 105.22 | 0.89 % | $ 1.33 B | USA |
 |
IRIDEX Corporation
IRIX
|
-11.2 | $ 1.42 | -0.7 % | $ 22.9 M | USA |
 |
Helius Medical Technologies
HSDT
|
-0.0925 | $ 2.31 | 16.67 % | $ 1.4 M | USA |
 |
Alphatec Holdings
ATEC
|
-8.6 | $ 13.15 | 1.0 % | $ 1.97 B | USA |
 |
Edwards Lifesciences Corporation
EW
|
39.2 | $ 85.49 | 0.26 % | $ 50 B | USA |